These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 8172678)

  • 21. Translocation of long peptides by transporters associated with antigen processing (TAP).
    Koopmann JO; Post M; Neefjes JJ; Hämmerling GJ; Momburg F
    Eur J Immunol; 1996 Aug; 26(8):1720-8. PubMed ID: 8765012
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Selectivity of MHC-encoded peptide transporters from human, mouse and rat.
    Momburg F; Roelse J; Howard JC; Butcher GW; Hämmerling GJ; Neefjes JJ
    Nature; 1994 Feb; 367(6464):648-51. PubMed ID: 8107849
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Spotlight on TAP and its vital role in antigen presentation and cross-presentation.
    Mantel I; Sadiq BA; Blander JM
    Mol Immunol; 2022 Feb; 142():105-119. PubMed ID: 34973498
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Presentation of numerous viral peptides to mouse major histocompatibility complex (MHC) class I-restricted T lymphocytes is mediated by the human MHC-encoded transporter or by a hybrid mouse-human transporter.
    Yewdell JW; Esquivel F; Arnold D; Spies T; Eisenlohr LC; Bennink JR
    J Exp Med; 1993 Jun; 177(6):1785-90. PubMed ID: 8496691
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A case of primary immunodeficiency due to a defect of the major histocompatibility gene complex class I processing and presentation pathway.
    Teisserenc H; Schmitt W; Blake N; Dunbar R; Gadola S; Gross WL; Exley A; Cerundolo V
    Immunol Lett; 1997 Jun; 57(1-3):183-7. PubMed ID: 9232449
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antigen presentation to cytotoxic T lymphocytes in vivo.
    Bevan MJ
    J Exp Med; 1995 Sep; 182(3):639-41. PubMed ID: 7650475
    [No Abstract]   [Full Text] [Related]  

  • 27. Selective and ATP-dependent translocation of peptides by the MHC-encoded transporter.
    Neefjes JJ; Momburg F; Hämmerling GJ
    Science; 1993 Aug; 261(5122):769-71. PubMed ID: 8342042
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Are transporter associated with antigen processing (TAP) and tapasin class I MHC chaperones?
    Solheim JC; Carreno BM; Hansen TH
    J Immunol; 1997 Jan; 158(2):541-3. PubMed ID: 8992965
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Major histocompatibility complex-linked transport proteins and antigen processing.
    Monaco JJ
    Immunol Res; 1992; 11(2):125-32. PubMed ID: 1431421
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The TAP complex influences allorecognition of class II MHC molecules.
    Carmichael P; Kerr LA; Kelly A; Lombardi G; Zeigler BU; Ziegler A; Trowsdale J; Lechler R
    Hum Immunol; 1996 Sep; 50(1):70-7. PubMed ID: 8872177
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Crystal structures of two rat MHC class Ia (RT1-A) molecules that are associated differentially with peptide transporter alleles TAP-A and TAP-B.
    Rudolph MG; Stevens J; Speir JA; Trowsdale J; Butcher GW; Joly E; Wilson IA
    J Mol Biol; 2002 Dec; 324(5):975-90. PubMed ID: 12470953
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The nature of the MHC class I peptide loading complex.
    Cresswell P; Bangia N; Dick T; Diedrich G
    Immunol Rev; 1999 Dec; 172():21-8. PubMed ID: 10631934
    [TBL] [Abstract][Full Text] [Related]  

  • 33. TAP prefers to transport melanoma antigenic peptides which are longer than the optimal T-cell epitope: evidence for further processing in the endoplasmic reticulum.
    Wang Y; Guttoh DS; Androlewicz MJ
    Melanoma Res; 1998 Aug; 8(4):345-53. PubMed ID: 9764810
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MHC class I molecules form ternary complexes with calnexin and TAP and undergo peptide-regulated interaction with TAP via their extracellular domains.
    Suh WK; Mitchell EK; Yang Y; Peterson PA; Waneck GL; Williams DB
    J Exp Med; 1996 Aug; 184(2):337-48. PubMed ID: 8760787
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antigen degradation or presentation by MHC class I molecules via classical and non-classical pathways.
    Grommé M; Neefjes J
    Mol Immunol; 2002 Oct; 39(3-4):181-202. PubMed ID: 12200050
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nucleotide binding to the hydrophilic C-terminal domain of the transporter associated with antigen processing (TAP).
    Müller KM; Ebensperger C; Tampé R
    J Biol Chem; 1994 May; 269(19):14032-7. PubMed ID: 8188683
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Processing and delivery of peptides presented by MHC class I molecules.
    Lehner PJ; Cresswell P
    Curr Opin Immunol; 1996 Feb; 8(1):59-67. PubMed ID: 8729447
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Overexpression of the ABC transporter TAP in multidrug-resistant human cancer cell lines.
    Izquierdo MA; Neefjes JJ; Mathari AE; Flens MJ; Scheffer GL; Scheper RJ
    Br J Cancer; 1996 Dec; 74(12):1961-7. PubMed ID: 8980397
    [TBL] [Abstract][Full Text] [Related]  

  • 39. How do endogenous proteins become peptides and reach the endoplasmic reticulum.
    Nandi D; Marusina K; Monaco JJ
    Curr Top Microbiol Immunol; 1998; 232():15-47. PubMed ID: 9557392
    [No Abstract]   [Full Text] [Related]  

  • 40. Assembly of tapasin-associated MHC class I in the absence of the transporter associated with antigen processing (TAP).
    Paulsson KM; Anderson PO; Chen S; Sjögren HO; Ljunggren HG; Wang P; Li S
    Int Immunol; 2001 Jan; 13(1):23-9. PubMed ID: 11133831
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.